The hyaluronic acid blood test measures hyaluronic acid, also called hyaluronan, in the bloodstream. In liver care, it is mainly used as a marker of connective-tissue turnover and liver fibrosis, which means scarring that can build up after long-term liver injury. Hyaluronic acid is a normal substance in the body, but blood levels can rise when the liver is not clearing it well or when scar-forming activity increases in the liver.
This test is not part of a standard liver panel, and it does not diagnose cirrhosis by itself. It is usually interpreted with other liver blood tests, platelet count, imaging, elastography, or fibrosis scores. A high result may point toward more advanced fibrosis, but inflammation, age, kidney function, arthritis, recent injury, and other conditions can also affect levels. The result is most useful when it helps decide whether someone needs closer liver evaluation, specialist review, or follow-up testing.
- Hyaluronic acid is a blood marker linked to liver fibrosis, extracellular matrix turnover, and reduced liver clearance.
- A high hyaluronic acid result can occur with advanced liver scarring, cirrhosis, active inflammation, aging, kidney disease, and some joint or connective-tissue conditions.
- There is no single universal normal range; many labs report results in ng/mL or µg/L and provide their own reference interval.
- Hyaluronic acid is used more often inside fibrosis panels, such as ELF or Hepascore, than as a stand-alone test.
- A normal result makes advanced fibrosis less likely in some settings, but it cannot rule out all liver disease.
- Follow-up usually includes liver enzymes, platelet count, bilirubin, albumin, INR, ultrasound, elastography, or fibrosis scores such as FIB-4.
Table of Contents
- What the Hyaluronic Acid Blood Test Measures
- Why Hyaluronic Acid Rises in Liver Fibrosis
- Normal Range, Units, and Result Levels
- High Hyaluronic Acid Blood Test Results
- How Results Are Interpreted With Other Liver Tests
- Accuracy, Strengths, and Limitations
- What to Do After an Abnormal Result
- Frequently Asked Questions
What the Hyaluronic Acid Blood Test Measures
The hyaluronic acid blood test measures the amount of hyaluronic acid circulating in serum or plasma. Hyaluronic acid is a large sugar-based molecule found in connective tissue, skin, joints, cartilage, blood vessels, and the extracellular matrix, which is the supportive framework around cells.
In everyday health topics, hyaluronic acid is often discussed as a skin or joint substance. In liver testing, the focus is different. The liver normally helps clear hyaluronic acid from the blood. Specialized liver cells called sinusoidal endothelial cells take up and break down circulating hyaluronic acid. When chronic liver disease damages this system, blood levels may rise.
Hyaluronic acid also increases when the body produces and remodels more extracellular matrix. Liver fibrosis is exactly that process: repeated injury causes the liver to lay down collagen, glycoproteins, and other matrix materials. Hyaluronic acid is one signal of that remodeling activity.
A hyaluronic acid result is therefore a “fibrosis activity and clearance” clue, not a direct picture of the liver. It does not show where scar tissue is located, how the liver looks, or whether a person has a specific cause of liver disease. It gives one piece of information about a process that often accompanies chronic liver injury.
Common reasons a clinician may order or review this marker include:
- chronic hepatitis B or hepatitis C monitoring
- metabolic dysfunction-associated steatotic liver disease, formerly often called fatty liver disease or NAFLD
- alcohol-related liver disease
- suspected advanced fibrosis or cirrhosis
- follow-up after abnormal liver enzymes or abnormal liver imaging
- use as part of a multi-marker fibrosis panel
Hyaluronic acid is rarely the first test ordered for liver symptoms. Most people start with routine liver function tests, a complete blood count, metabolic markers, viral hepatitis testing when relevant, and imaging. Hyaluronic acid becomes more useful when the clinical question turns from “Is there liver injury?” to “Is there meaningful fibrosis?”
Why Hyaluronic Acid Rises in Liver Fibrosis
Hyaluronic acid rises in liver fibrosis for two main reasons: the liver may clear less of it, and fibrotic tissue may produce more of it.
A healthy liver filters blood from the gut and systemic circulation through tiny channels called sinusoids. The cells lining these channels remove hyaluronic acid efficiently. In chronic liver disease, these cells can lose function. As scar tissue forms, blood flow through the liver also changes. The result is slower or less effective clearance.
At the same time, liver injury activates hepatic stellate cells. These cells normally store vitamin A, but after repeated injury they transform into scar-producing cells. They release collagen and other extracellular matrix components. Hyaluronic acid can increase as part of this tissue-remodeling response.
This is why hyaluronic acid tends to track better with fibrosis than with a single short-lived liver enzyme spike. ALT and AST can rise quickly when liver cells are irritated or injured. Hyaluronic acid more often reflects structural remodeling and impaired clearance, especially when elevations persist.
That said, fibrosis is not a simple on/off condition. It develops in stages. Many biopsy systems describe fibrosis from F0 to F4:
| Stage | General meaning | How hyaluronic acid may behave |
|---|---|---|
| F0 | No fibrosis | Often normal, though non-liver factors can still raise it |
| F1 | Mild fibrosis | May be normal or mildly increased |
| F2 | Significant fibrosis | May rise, but overlap with milder stages is common |
| F3 | Advanced fibrosis | More likely to be elevated |
| F4 | Cirrhosis | Often elevated, especially when liver clearance is impaired |
Hyaluronic acid is better at suggesting advanced scarring than precisely separating every stage. A person with F1 and a person with F2 may have overlapping results. A person with F3 may have a higher result, but the number still needs context.
This is one reason modern liver assessment often combines several signals. A clinician may compare hyaluronic acid with platelet count, AST, ALT, bilirubin, albumin, INR, ultrasound findings, liver stiffness, and symptoms. A high fibrosis marker becomes more convincing when several other findings point in the same direction.
Normal Range, Units, and Result Levels
There is no single worldwide normal range for the hyaluronic acid blood test. Laboratories use different methods, sample types, calibration systems, and reporting units. The reference interval printed on the lab report is the range that should be used for that specific result.
Most reports use either ng/mL or µg/L. These units are numerically equivalent for this test: 1 ng/mL equals 1 µg/L. Some labs may report nmol/L or use panel-specific scoring rather than a simple hyaluronic acid concentration.
Many clinical discussions treat values below roughly 75 to 100 ng/mL as more likely to be within an adult reference range, but this is only a rough guide. Some studies and laboratories use lower or higher cutoffs depending on age, liver disease type, and the purpose of testing.
| Result pattern | Possible meaning | Important caution |
|---|---|---|
| Within the lab reference range | Advanced fibrosis is less likely in many settings | Does not rule out early fibrosis, fatty liver, hepatitis, or mild liver injury |
| Mildly high | May reflect early fibrosis, inflammation, age-related increase, or non-liver causes | Often needs repeat testing or comparison with other liver markers |
| Moderately high | Raises concern for more active matrix turnover or reduced liver clearance | Interpret with platelet count, liver enzymes, bilirubin, albumin, INR, and imaging |
| Markedly high | Can be seen with advanced fibrosis, cirrhosis, severe inflammation, or impaired clearance | Needs medical review, especially with jaundice, swelling, bleeding, confusion, or low platelets |
A number near the upper limit should not be read the same way in every person. For example, a mildly high result in a young adult with high ALT, low platelets, and abnormal ultrasound is more concerning than the same result in an older adult with normal liver tests and active arthritis.
Age matters because hyaluronic acid can increase as people get older. Kidney function may matter because reduced clearance outside the liver can affect blood levels. Inflammation and tissue injury may matter because hyaluronic acid is not specific to the liver.
The most reliable interpretation starts with these questions:
- What reference range did the testing lab provide?
- Was the result repeated or checked only once?
- Are AST, ALT, GGT, ALP, bilirubin, albumin, INR, and platelets normal?
- Is there known fatty liver, viral hepatitis, alcohol-related liver disease, autoimmune liver disease, or cholestatic disease?
- Are there symptoms or imaging findings that suggest cirrhosis or portal hypertension?
- Was hyaluronic acid measured alone or as part of a validated fibrosis panel?
When hyaluronic acid is included in the ELF test, the final score matters more than the individual hyaluronic acid value. ELF combines hyaluronic acid with PIIINP and TIMP-1 to estimate fibrosis risk. That is different from reading hyaluronic acid as a stand-alone marker.
High Hyaluronic Acid Blood Test Results
A high hyaluronic acid result means the level in the blood is above the laboratory’s reference interval or above a clinical cutoff used for a specific fibrosis assessment. In liver medicine, the main concern is significant fibrosis or cirrhosis, but the result is not specific enough to prove that by itself.
Liver-related causes of high hyaluronic acid
Chronic liver diseases that can raise hyaluronic acid include:
- metabolic dysfunction-associated steatotic liver disease
- chronic hepatitis B
- chronic hepatitis C
- alcohol-related liver disease
- autoimmune hepatitis
- primary biliary cholangitis
- primary sclerosing cholangitis
- drug-related chronic liver injury
- advanced cirrhosis from many causes
In these conditions, hyaluronic acid may rise as fibrosis increases. The result may be especially concerning when paired with low platelets, a high AST/ALT ratio, high bilirubin, low albumin, prolonged INR, enlarged spleen, or signs of portal hypertension.
Some liver patterns deserve special attention. A person with fatty liver and normal or mildly abnormal ALT can still have fibrosis. Liver enzymes do not always rise in proportion to scarring. This is why fibrosis assessment may be needed even when standard enzymes look only mildly abnormal.
Hyaluronic acid can also rise in active inflammatory liver disease. Inflammation and fibrosis often occur together, but they are not the same thing. A flare of hepatitis may change biomarkers temporarily. Repeating tests after the flare improves interpretation.
Non-liver causes of high hyaluronic acid
High hyaluronic acid can also come from conditions outside the liver. Possible non-liver influences include:
- older age
- rheumatoid arthritis or other inflammatory joint disease
- connective tissue disease
- recent injury, surgery, or tissue repair
- severe systemic inflammation
- kidney dysfunction
- some cancers
- intense tissue turnover from non-hepatic disease
This matters because the test is measuring a molecule used throughout the body. The liver is important for clearance, but it is not the only source of hyaluronic acid.
A high result should therefore prompt a pattern-based review rather than a single-test conclusion. If liver enzymes, platelet count, albumin, INR, and imaging are normal, the clinician may consider non-liver causes or repeat the test. If several liver-related results are abnormal, the high hyaluronic acid level becomes more meaningful.
Symptoms that make a high result more urgent
Many people with fibrosis have no symptoms. However, a high hyaluronic acid result should be reviewed promptly if it occurs with signs that may suggest advanced liver disease or complications.
Seek timely medical care for:
- yellow skin or eyes
- new abdominal swelling
- vomiting blood or black stools
- easy bruising or unusual bleeding
- confusion, sleepiness, or personality changes
- severe right upper abdominal pain
- unexplained weight loss
- fever with jaundice
- new leg swelling
- very dark urine with pale stools
These symptoms are not caused by hyaluronic acid itself. They may indicate liver dysfunction, bile obstruction, bleeding risk, infection, or other serious problems that need direct medical evaluation.
How Results Are Interpreted With Other Liver Tests
Hyaluronic acid works best as part of a broader fibrosis assessment. It should be interpreted with tests that answer different liver questions.
ALT and AST show liver cell injury. ALP and GGT help identify bile duct or cholestatic patterns. Bilirubin reflects bile processing and excretion. Albumin and INR help assess liver synthetic function, which means the liver’s ability to make important proteins and clotting factors. Platelet count can fall when portal hypertension develops from advanced scarring.
A useful comparison is:
| Test or marker | Main information it gives | How it helps interpret hyaluronic acid |
|---|---|---|
| ALT and AST | Liver cell injury or irritation | High enzymes plus high hyaluronic acid may suggest active injury with fibrosis risk |
| GGT and ALP | Bile duct or cholestatic pattern | May point toward bile duct disease or alcohol-related patterns when abnormal |
| Bilirubin | Bile processing, jaundice risk, liver excretion | High bilirubin with high hyaluronic acid may suggest more advanced disease or obstruction |
| Albumin and INR | Liver synthetic function | Low albumin or high INR makes advanced liver dysfunction more concerning |
| Platelet count | Possible portal hypertension or marrow/immune effects | Low platelets strengthen concern for advanced fibrosis or cirrhosis |
| Elastography | Liver stiffness | Helps confirm whether blood marker changes match increased stiffness |
If liver enzymes are abnormal, a hepatic function panel helps separate patterns of liver cell injury, bile duct stress, and impaired liver function. If albumin is low or INR is high, interpretation should include albumin and INR because they can suggest reduced liver reserve in the right clinical setting.
Fibrosis scores also matter. The FIB-4 index uses age, AST, ALT, and platelet count. APRI uses AST and platelet count. These scores are inexpensive and widely used as first-pass tools. A high hyaluronic acid result that agrees with an elevated FIB-4 or APRI is more concerning than a high hyaluronic acid result in isolation.
More complex panels may include hyaluronic acid directly. The ELF test combines hyaluronic acid, PIIINP, and TIMP-1. Hepascore includes hyaluronic acid with other markers such as bilirubin and GGT. These panels use algorithms designed to improve accuracy beyond any single marker.
Elastography is often the next important step. Transient elastography, commonly known by the brand name FibroScan, estimates liver stiffness with ultrasound-based technology. Magnetic resonance elastography can be used in some centers. These tests do not replace clinical judgment, but they add a physical measurement of stiffness that blood tests cannot provide.
A practical interpretation might look like this:
- High hyaluronic acid + low platelets + high liver stiffness: advanced fibrosis is more likely.
- High hyaluronic acid + normal platelets + normal liver stiffness: consider repeat testing and non-liver causes.
- Normal hyaluronic acid + high FIB-4: do not ignore the risk; review age, AST, ALT, platelets, and imaging.
- Mildly high hyaluronic acid during acute hepatitis: repeat after inflammation improves.
- High hyaluronic acid in a known arthritis flare: interpret cautiously and avoid assuming the liver is the only source.
The pattern is more important than the isolated number.
Accuracy, Strengths, and Limitations
The hyaluronic acid blood test has real value, but it has clear limits. It is best viewed as a supportive fibrosis marker rather than a stand-alone diagnostic test.
Its main strength is that it reflects a process closely related to fibrosis: extracellular matrix turnover and impaired liver clearance. It can be helpful when routine liver enzymes do not fully show fibrosis risk. It can also add value inside multi-marker panels.
Another strength is convenience. It is a blood test, so it is easier to repeat than liver biopsy and does not require imaging equipment. It may help monitor changes over time, especially when used consistently with the same lab method or panel.
The largest limitation is lack of specificity. High hyaluronic acid does not prove liver fibrosis. It can rise from non-liver inflammation, aging, kidney disease, joint disease, and tissue repair. Even within liver disease, it cannot reliably tell the exact fibrosis stage by itself.
The second limitation is stage overlap. Early and moderate fibrosis may overlap with normal results. A person can have meaningful liver disease with a normal hyaluronic acid value, especially if fibrosis is mild, disease is patchy, or the test is being used outside a validated setting.
The third limitation is lab variation. Different assays can produce different reference intervals. A result from one lab may not match another lab perfectly. This is especially important when tracking changes over time. A change from 70 to 90 ng/mL may not mean much if the test method changed.
The fourth limitation is timing. Hyaluronic acid may shift during active inflammation, acute illness, recent injury, or changes in kidney function. A single result taken during an unstable medical period may not represent the person’s usual baseline.
The fifth limitation is clinical fit. A fibrosis marker is most useful when the person has a reason to suspect chronic liver disease. In someone with no liver risk factors, normal liver enzymes, normal platelet count, and normal imaging, a mildly high hyaluronic acid value may lead to unnecessary worry unless it is interpreted carefully.
This is why many guidelines and liver specialists use stepwise assessment. Simple scores such as FIB-4 and APRI may be used first. Indeterminate or high-risk results may lead to elastography, ELF testing, specialist referral, or sometimes biopsy. Hyaluronic acid can fit into that process, but it should not replace it.
What to Do After an Abnormal Result
An abnormal hyaluronic acid result should lead to a structured review, not panic. The next step depends on how high the value is, why the test was ordered, and whether other liver markers are abnormal.
A typical follow-up plan may include:
- Confirm the reference range. Use the range printed on the lab report. Do not compare the result with random online cutoffs unless they match the same method and clinical context.
- Review the full liver pattern. AST, ALT, ALP, GGT, bilirubin, albumin, INR, and platelet count help show whether there is active liver injury, bile duct stress, impaired liver function, or possible portal hypertension. A high GGT result, for example, can support alcohol-related, bile duct, medication-related, or fatty liver patterns depending on the rest of the workup.
- Check common causes of chronic liver disease. Depending on the person, this may include viral hepatitis testing, metabolic risk review, alcohol history, medication and supplement review, autoimmune markers, iron studies, and imaging.
- Estimate fibrosis risk with a score. FIB-4 is often used because it relies on routine labs. APRI may also be used. These scores are not perfect, but they help decide who needs further testing.
- Consider liver stiffness testing. Elastography can help confirm whether the blood marker pattern matches increased liver stiffness. This is especially useful when blood tests are mixed or borderline.
- Repeat testing when timing may have affected the result. If the result was drawn during acute illness, hepatitis flare, surgery recovery, injury, or systemic inflammation, repeating later may give a clearer picture.
- Refer when risk is moderate or high. A hepatologist or gastroenterologist can decide whether advanced fibrosis workup, surveillance, treatment, or biopsy is needed.
Lifestyle and cause-specific treatment matter more than the hyaluronic acid number itself. If metabolic fatty liver disease is suspected, weight loss when appropriate, improved insulin resistance, regular physical activity, blood pressure control, triglyceride control, and diabetes care can reduce liver risk. If alcohol is contributing, reducing or stopping alcohol is central. If viral hepatitis is present, antiviral treatment can slow or reverse fibrosis progression in many people. If autoimmune or cholestatic liver disease is present, treatment is different and should be guided by a clinician.
Do not start supplements to “lower hyaluronic acid” without medical guidance. The goal is not to force the marker down. The goal is to find and treat the cause of liver injury or non-liver inflammation.
Frequently Asked Questions
Is hyaluronic acid a liver function test?
Hyaluronic acid is not a liver function test in the same way albumin, INR, or bilirubin can reflect liver function. It is better described as a liver fibrosis or extracellular-matrix turnover marker. It may rise when the liver has more fibrosis or clears hyaluronic acid less effectively, but it does not directly measure how well the liver is making proteins, processing bile, or detoxifying substances.
Can a high hyaluronic acid blood test diagnose cirrhosis?
No. A high result can support concern for advanced fibrosis or cirrhosis, but it cannot diagnose cirrhosis by itself. Diagnosis usually depends on a combination of history, physical exam, blood tests, platelet count, imaging, elastography, endoscopy findings when relevant, and sometimes liver biopsy.
Can hyaluronic acid be high if liver enzymes are normal?
Yes. Liver enzymes can be normal or only mildly abnormal in some people with fibrosis, especially in metabolic fatty liver disease or stable cirrhosis. Hyaluronic acid can also be high for non-liver reasons. A normal ALT or AST does not automatically make a high fibrosis marker meaningless, but it does make pattern-based interpretation essential.
Does a normal hyaluronic acid result rule out liver fibrosis?
No. A normal result makes advanced fibrosis less likely in some settings, but it does not rule out early fibrosis, mild chronic hepatitis, fatty liver disease, or all forms of liver injury. If other tests suggest risk, further evaluation may still be needed.
Is hyaluronic acid the same as the ELF test?
No. Hyaluronic acid is one marker. The ELF test is a panel that combines hyaluronic acid with PIIINP and TIMP-1 in an algorithm. The ELF score is generally more informative than the hyaluronic acid value alone because it uses multiple fibrosis-related signals.
Can supplements or skin products affect the blood test?
Topical hyaluronic acid skin products are unlikely to meaningfully affect a liver fibrosis blood test. Oral supplements are less predictable, and their effect on serum testing is not the main concern in clinical liver interpretation. Tell your clinician about supplements, injections, joint treatments, and medications so the result can be interpreted accurately.
Should the test be repeated?
Repeat testing may be useful if the result is unexpected, borderline, or drawn during acute illness or inflammation. It is most helpful when repeated with the same laboratory method and interpreted with the same set of liver markers. Repeating the test without a broader plan may not clarify much.
What result level is dangerous?
There is no single hyaluronic acid number that defines danger for everyone. A very high result is more concerning when it appears with low platelets, high bilirubin, low albumin, high INR, abnormal imaging, or symptoms of liver decompensation. Symptoms such as jaundice, confusion, vomiting blood, black stools, or new abdominal swelling need prompt medical care regardless of the hyaluronic acid level.
References
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update 2021 (Guideline)
- AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease 2023 (Guidance)
- Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection 2005 (Clinical Study)
- European Liver Fibrosis Group: a multicenter, prospective study of serum markers of liver fibrosis in chronic hepatitis C 2005 (Clinical Study)
- Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease 2020 (Review)
- Non-alcoholic fatty liver disease (NAFLD): assessment and management 2016 (Guideline)
Disclaimer
A hyaluronic acid blood test result should be interpreted by a qualified healthcare professional who can review your symptoms, medical history, medications, liver enzymes, platelet count, imaging, and fibrosis risk factors. This article is for general education and cannot diagnose liver fibrosis, cirrhosis, or the cause of an abnormal result.
